
Product News
Launch of High-Quality Enzymes Suitable for Pre-Clinical and Process Development in mRNA Vaccine
Takara Bio Europe announced the launch of new High Quality grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatase (inorganic), HQ" suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.

Product News
Accelerating Cell Therapies with Manufacturing Breakthrough
Thermo Fisher announced a first of its kind technology to help accelerate the molecule-to-market process by driving efficiency and reducing manufacturing costs.

Product News
TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration
TherageniX, have been awarded a £995,000 grant from Innovate UK. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery.

Product News
Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering
Optibrium, announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing decades of experience in computational chemistry and biology.

Product News
Polyplus Launches FectoVIR®-LV Transfection Reagent with New DOE Service Options
Polyplus (now part of Satorius), is announcing the pre-order availability of FectoVIR®-LV transfection reagent for lentiviral vector (LV) production.

Product News
NIH and Exothera Collaborate To Produce GMP Intranasal Vaccine Against SARS-CoV-2
The National Institutes of Health selected Exothera S.A. therapeutics to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2.

Product News
MaxCyte Signs Strategic Platform License With Prime Medicine To Advance Next-Generation Gene Editing Therapies
MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), announced the signing of a strategic partnership with Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies.

Product News
Waters Corporation Launches PeptideWorks™ Tryptic Protein Digestion Kits
Waters enables automated, high efficiency, and reproducible protein digestion with meaningful sample prep savings.

Product News
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
TVM Capital Life Science, together with specialty pharma company, Tillotts Pharma has announced that the companies will jointly invest up to USD 28 million in the newly formed U.S.-based biotechnology company, Mage Biologics Inc.

Product News
Cytiva Launches System To Enable End-to-End Manufacturing of Lipid Nanoparticle Medicines
Cytiva has launched the NanoAssemblr commercial formulation system, purpose-built for clinical and commercial manufacturing of lipid nanoparticle medicines.
Advertisement